Process for Obtaining Botulinum Neurotoxin
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 11 of these applications claim priority to application 12/502,181, filed Jul 13, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,927,229 | Process and System for Obtaining Botulinum Neurotoxin In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 9,719,076 | Process and System for Obtaining Botulinum Neurotoxin In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 10,465,178 | Process and System for Obtaining Botulinum Neurotoxin In force · Medium confidence | Allergan, Inc. | In force | Medium confidence | ||
| US 11,124,786 | Process and System for Obtaining Botulinum Neurotoxin In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 11,203,748 | Process and System for Obtaining Botulinum Neurotoxin In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 11,326,155 | Process and System for Obtaining Botulinum Neurotoxin In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 11,518,986 | Process and System for Obtaining Botulinum Neurotoxin In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 11,525,130 | Process and System for Obtaining Botulinum Neurotoxin In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 11,530,400 | Process and System for Obtaining Botulinum Neurotoxin In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 12,241,098 | Process and System for Obtaining Botulinum Neurotoxin In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| 7 more patents in this group · Pro | ||||||
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17, including 1 expired.
12 of these are in force and held by Allergan, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.